ALX Oncology (ALXO) Appoints Alan Sandler to its Board

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. WCN
6. SPOT
7. BMY
8. SPY
9. FIX
10. TSCO

Go back to ALX Oncology (ALXO) Appoints Alan Sandler to its Board

ALX Oncology Appoints Alan Sandler, M.D., to Board of Directors

August 6, 2024 4:01 PM EDT

- Dr. Sandler brings more than 30 years of experience and leadership in oncology and drug development -

- Jaume Pons, Ph.D., and Sophia Randolph, M.D., Ph.D., will leave board to focus on ALX leadership responsibilities as Companys clinical program advances -

SOUTH SAN FRANCISCO, Calif., Aug. 06, 2024 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc. (ALX Oncology or the Company) (Nasdaq: ALXO), an immuno-oncology company developing therapies that block the CD47 immune checkpoint pathway, announced today the appointment of Alan Sandler, M.D., to its Board of Directors effective... More